|
Company:
|
EXAGEN INC. (XGN)
|
|
Form Type:
|
4
|
|
Filing Date:
|
5/22/2020
|
|
CIK:
|
0001274737
|
|
Address:
|
1261 LIBERTY WAY
|
|
City, State, Zip:
|
VISTA, California 92081
|
|
Telephone:
|
(760) 560-1501
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$11.25
|
Change:
0.11 (0.99%)
|
Trade Time:
Jun 02
|
Market Cap:
$142.20M
|
|
|
|
|
|
|
Description of Business
|
|
Exagen is dedicated to transforming the care continuum for patients suffering
from debilitating and chronic autoimmune diseases by enabling timely
differential diagnosis and optimizing therapeutic intervention. We have
developed and are commercializing a portfolio of innovative testing products
under our AVISE® brand, several of which are based on our proprietary Cell-Bound
Complement Activation Products, or CB-CAPs, technology. CB-CAPs assess the
activation of the complement system, a biological pathway that is widely
implicated across many autoimmune and autoimmune-related diseases, including
systemic lupus erythematosus, or SLE. Our goal is to enable rheumatologists to
improve care for patients through the differential diagnosis, prognosis and
monitoring of complex autoimmune and autoimmune-related diseases, including SLE
and rheumatoid arthritis, or RA.
|
|
|
|